EUCTR2005-001463-64-IT进行中（未招募）不适用
A phase II study of intravenous IV vinflunine in patients with locally advanced or metastatic transitional cell carcinoma TCC of the urothelium.
BRISTOL-M.SQUIBB0 个研究点目标入组 160 人开始时间: 2006年5月9日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Phase II Study of Intravenous (IV) Vinflunine in Patients with Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the UrotheliumRevised Protocol #05, incorporating Protocol Amendments 04, 07, 08 and 10;+ Pharmacokinetics Blood Sample Amendment #03 dated 18-Oct-05+ Amendment #06, dated 24-Feb-06Advanced Cancer, IV, NosEUCTR2005-001463-64-SEBristol-Myers Squibb International Corporation150
进行中（未招募）
不适用
A Phase II Study of Intravenous (IV) Vinflunine in Patients with Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the UrotheliumRevised Protocol #01, version 2.0 incorporating Protocol Amendment #04, andPharmacogenetics Blood Sample Amendment #01, dated 18-Oct-04Primary Tumor Tissue Sample Amendment #02, dated 18-Oct-04Pharmacokinetics Blood Sample Amendment #03, dated 18-Oct-04Advanced Cancer, IV, NosEUCTR2005-001463-64-ATBristol-Myers Squibb International Corporation150
进行中（未招募）
1 期
study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic head and neck cancer previously treated with platinum-based chemotherapyrecurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapyMedDRA version: 18.1 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005081-38-DEPIERRE FABRE MEDICAMENT459
进行中（未招募）
1 期
study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic head and neck cancer previously treated with platinum-based chemotherapyrecurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapyMedDRA version: 17.1Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005081-38-PLPIERRE FABRE MEDICAMENT459
进行中（未招募）
1 期
study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic head and neck cancer previously treated with platinum-based chemotherapyrecurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapyMedDRA version: 19.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005081-38-BEPIERRE FABRE MEDICAMENT459